| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 10/11/2006 | EP1469851B1 Melanocortin receptor agonists |
| 10/11/2006 | EP1430045B1 Pyrane derivatives as both ace- and nep-inhibitors |
| 10/11/2006 | EP1363903B1 Indole derivatives and their use as gnrh antagonists |
| 10/11/2006 | CN1845924A Arylamine-substituted quinazolinone compounds |
| 10/11/2006 | CN1845922A Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
| 10/11/2006 | CN1845918A Pyrimidines useful as modulators of voltage-gated ion channels |
| 10/11/2006 | CN1845915A Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 10/11/2006 | CN1845908A 5-substituted quinazolinone derivatives |
| 10/11/2006 | CN1845901A CCK-1 receptor modulators |
| 10/11/2006 | CN1845900A Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 10/11/2006 | CN1845734A Benzimidazole derivatives and their use as protein kinases inhibitors |
| 10/11/2006 | CN1845673A Pyridinylanilides |
| 10/11/2006 | CN1844105A Beta-elemene derivatives containing nitrogen and their preparation method and use |
| 10/11/2006 | CN1279034C Dna－pk抑制剂 Dna-pk inhibitors |
| 10/11/2006 | CN1279026C Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 10/10/2006 | US7119221 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders |
| 10/10/2006 | US7119214 dibenzofuranyl, dibenzothiophenyl or fluorenyl thioacetamides used for prophylaxis of sleep disorders |
| 10/10/2006 | US7119208 drugs that bind to and increases oxygen affinity of hemoglobin, and preventing polymerization and formation fibrous precipitates hemoglobin, used for treatment of sickle-cell disease |
| 10/10/2006 | US7119207 NK-1 receptor antagonists, (e.g., substance P receptor antagonists) |
| 10/10/2006 | US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 10/10/2006 | US7119202 Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties |
| 10/10/2006 | US7119120 A 2-benzenesulfonylamino-N-benzyl-benzamides for treating hyperphosphatemia, urogential disorders |
| 10/10/2006 | US7119116 Direct aminolysis of a carbamate ester or hydrolysis to an acid followed by coupling with an amine; analgesics, disorders of eating, nervous system, psychology, sleep, urogenital, respiratory and gastrointestinal systems; antiischemic, anticarcinogenic, antiinflammatory agents, antiallergens |
| 10/10/2006 | US7119105 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 10/10/2006 | US7119104 Alpha-(oxy-, sulfo- or amino-)[3-(imidazolyl, oxazolyl or thiazolyl)alkylene(indazolyl, benzisoxazolyl or benzisothiazolyl)]acetic acids, esters or alkali salts |
| 10/10/2006 | US7119103 β3-Adrenoreceptor agonists, agonist compositions and methods of using |
| 10/10/2006 | US7119099 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives |
| 10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
| 10/10/2006 | US7119097 2-(4,6-dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid; formulations for oral, parenteral, or nasopharyngeal delivery; endothelin receptor antagonist |
| 10/10/2006 | US7119084 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders |
| 10/10/2006 | US7118811 Materials for light emitting devices consisting of novel compounds and light emitting devices using the same |
| 10/10/2006 | CA2336000C N-substituted piperazines and 1,4-disubstituted piperidines |
| 10/10/2006 | CA2298398C Baccatin derivatives and a process for producing the same |
| 10/10/2006 | CA2255951C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 10/10/2006 | CA2248068C Substituted aryl sulphonyl(thio)ureas used as herbicides |
| 10/10/2006 | CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 10/05/2006 | WO2006104713A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006103511A1 Cyclopentapyridine and tetrahydroquinoline derivatives |
| 10/05/2006 | WO2006103275A1 3,4,5-substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006102958A1 Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives |
| 10/05/2006 | WO2006102759A1 Novel substituted 2-nitroimidazoles useful for hypoxic cell therapy and imaging |
| 10/05/2006 | WO2006087630A3 OXYPYRAZOLE HMG Co-A REDUCTASE INHIBITORS |
| 10/05/2006 | WO2006014483A3 Epoxidized esters of vegetable oil fatty acids as reactive diluents |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | US20060223860 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223859 Chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223858 Chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 10/05/2006 | US20060223828 Substituted chroman derivatives |
| 10/05/2006 | US20060223826 Indole derivatives as somatostatin agonists or antagonists |
| 10/05/2006 | US20060223823 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/05/2006 | US20060223822 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/05/2006 | US20060223814 Nk-2 antagonist basic linear compounds and formulations containing them |
| 10/05/2006 | US20060223784 Method and compositions for temporarily incapacitating subjects |
| 10/05/2006 | US20060223758 Treating treating angiogenic disease by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; stability |
| 10/05/2006 | US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 10/05/2006 | US20060223708 Substituted N-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators |
| 10/05/2006 | US20060223151 Production of polyketides |
| 10/05/2006 | US20060219990 Substituted phenanthropyrans |
| 10/05/2006 | DE102005015253A1 New pyrazole derivatives are tyrosine kinase inhibitors useful to treat e.g. solid tumors, diabetic retinopathy, age-related macular degeneration or inflammatory disease, osteoarthritis and rickets |
| 10/05/2006 | DE102005000666B3 Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Sulfonylpyrrolidine, processes for their preparation and their use as medicaments |
| 10/05/2006 | CA2602510A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 10/05/2006 | CA2601126A1 Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives |
| 10/05/2006 | CA2601108A1 3,4,5-substituted piperidines as renin inhibitors |
| 10/04/2006 | EP1707563A2 Methods and compositions utilizing quinazolinones |
| 10/04/2006 | EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative |
| 10/04/2006 | EP1706402A1 Cathepsin cysteine protease inhibitors |
| 10/04/2006 | EP1706398A1 Amino-benzazoles as p2y1 receptor inhibitors |
| 10/04/2006 | EP1527067B1 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines |
| 10/04/2006 | EP1492786B1 Pyridinoylpiperidines as 5-ht1f agonists |
| 10/04/2006 | EP1458376B1 Darifenacin for use in the treatment of urgency induced by overactive bladder |
| 10/04/2006 | EP1451178A4 Processes for preparing beta-d-ribofuranose derivatives |
| 10/04/2006 | EP1409481B1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 10/04/2006 | EP1385840B1 Sulfonamides |
| 10/04/2006 | EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 10/04/2006 | EP1322621B1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 10/04/2006 | EP1097382B1 Imidazoline receptor binding compounds |
| 10/04/2006 | EP0841925B1 Endothelin receptor antagonists |
| 10/04/2006 | CN1842528A Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 10/04/2006 | CN1842527A Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or chlolic acid derivatives |
| 10/04/2006 | CN1842272A Hydrazone derivatives for combatting harmful insects and arachnids |
| 10/04/2006 | CN1277824C Piperazine derivatives |
| 10/04/2006 | CN1277822C Quinazoline derivatives, pharmaceutical composition containing the compound, their utilization and preparation method thereof |
| 10/04/2006 | CN1277820C Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/03/2006 | US7115752 Substituted cyclic compounds |
| 10/03/2006 | US7115750 Melanin concentrating hormone antagonist |
| 10/03/2006 | US7115745 Benzyl urea and thiourea derivatives |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115658 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus. |
| 10/03/2006 | US7115645 Central nervous system disorders; antiinflammatory agents |
| 10/03/2006 | US7115644 Antiinflammatory agents; osteoarthritic; antihistamines; multiple sclerosis; antiulcer agents; skin disorders; graft versus host disease; abtidiabetic agents; Alzheimer's disease; antidiabetic agents |
| 10/03/2006 | US7115634 4-aminopiperidine and their use as a medicine |
| 10/03/2006 | US7115630 Metabotropic glutamate receptor antagonists |
| 10/03/2006 | US7115627 Trypsin-like serine protease enzyme inhibitors; anticoagulants |
| 10/03/2006 | US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 10/03/2006 | US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline |
| 10/03/2006 | US7115609 Compounds containing particular phenyl, indolyl or benzo[b]thiophenyl groups, a glycine residue bearing a substituted alkyl group and a 4-(1-methyl-piperidin-4-yl)piperidin-1-yl or 4-(1-methylpiperidin-4-yl)piperazin-1-yl group; Factor Xa inhibitors, thrombotic disorder |
| 10/03/2006 | US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties |